Landry Robert E bought REGN
January 12, 2024 · Form 4 insider transaction
Landry Robert E bought 800 shares of Regeneron Pharmaceuticals, Inc. at $378.98 per share, a transaction worth $303.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
800
Price
$378.98
Total value
$303.2K
InsiderLandry Robert E
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 12, 2024
Filing dateJanuary 17, 2024
Shares owned after23,406
OwnershipDirect
10b5-1 planNo
AmendedNo